Pulmonx Corporation Share Holder Equity 2019-2024 | LUNG
Pulmonx Corporation share holder equity from 2019 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Pulmonx Corporation Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $118 |
| 2022 | $154 |
| 2021 | $193 |
| 2020 | $226 |
| 2019 | $18 |
| 2018 | $-27 |
| Pulmonx Corporation Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $94 |
| 2024-06-30 | $101 |
| 2024-03-31 | $110 |
| 2023-12-31 | $118 |
| 2023-09-30 | $126 |
| 2023-06-30 | $134 |
| 2023-03-31 | $144 |
| 2022-12-31 | $154 |
| 2022-09-30 | $163 |
| 2022-06-30 | $172 |
| 2022-03-31 | $182 |
| 2021-12-31 | $193 |
| 2021-09-30 | $203 |
| 2021-06-30 | $210 |
| 2021-03-31 | $217 |
| 2020-12-31 | $226 |
| 2020-09-30 | $-207 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2018-12-31 | $-27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||